Cargando…
Protease Inhibition—An Established Strategy to Combat Infectious Diseases
Therapeutic agents with novel mechanisms of action are urgently needed to counter the emergence of drug-resistant infections. Several decades of research into proteases of disease agents have revealed enzymes well suited for target-based drug development. Among them are the three recently validated...
Autores principales: | Sojka, Daniel, Šnebergerová, Pavla, Robbertse, Luïse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197795/ https://www.ncbi.nlm.nih.gov/pubmed/34071206 http://dx.doi.org/10.3390/ijms22115762 |
Ejemplares similares
-
Plasmepsin-like Aspartyl Proteases in Babesia
por: Šnebergerová, Pavla, et al.
Publicado: (2021) -
Strategies to Combat Multidrug-Resistant and Persistent Infectious Diseases
por: Pacios, Olga, et al.
Publicado: (2020) -
Bioprinting for combating infectious diseases
por: Zimmerling, Amanda, et al.
Publicado: (2020) -
Peptides to combat viral infectious diseases
por: Al-Azzam, Shams, et al.
Publicado: (2020) -
Immune Complex Vaccine Strategies to Combat HIV-1 and Other Infectious Diseases
por: Tang, Alex F., et al.
Publicado: (2021)